Hepatocellular Carcinoma Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 January 08
SKU : PH363
180 pages
Report Summary
Table of Contents
List of Tables & Figures
Buy this report
Single User
$4350
Multiple User
$4850
Enterprise User
$7850
Request new version
FAQ’s
How big is the Hepatocellular Carcinoma Market ?
Global Hepatocellular Carcinoma Market reached USD 977 million in 2022 and is expected to reach USD 2.4 billion by 2031.
Who are the Key Players of Hepatocellular Carcinoma Market ?
Major players are Teva Pharmaceutical Industries Ltd., Bristol Myers Squibb, Novartis AG, Bayer AG, F. Hoffmann-La Roche Ltd, Polaris Pharmaceuticals Inc., Creative Diagnostics, Harbour BioMed and Merck & Co. Inc.
Related Reports
pharmaceuticalsPancreatic Cancer Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2023 December 04
Starting from
$4350
pharmaceuticalsNon Melanoma Skin Cancer Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 February 23
Starting from
$4350
pharmaceuticalsMultiple Myeloma Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 March 06
Starting from
$4350
pharmaceuticalsVulvar Cancer Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 January 24
Starting from
$4350
pharmaceuticalsGlioblastoma Treatment Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 January 23
Starting from
$4350
pharmaceuticalsOncolytic Virus Therapy Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 January 05
Starting from
$4350